DrugPatentWatch Database Preview

Organon Usa Inc Company Profile

ORGANON USA INC has thirty approved drugs.

There are seven US patents protecting ORGANON USA INC drugs. There is one tentative approval on ORGANON USA INC drugs.

There are one hundred and forty-six patent family members on ORGANON USA INC drugs in thirty-nine countries and thirty-two supplementary protection certificates in eleven countries.

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Organon Usa Inc	ZEMURON	rocuronium bromide	INJECTABLE;INJECTION	020214-001	Mar 17, 1994		DISCN	Yes	No		➤ Sign Up				➤ Sign Up
Organon Usa Inc	PREGNYL	gonadotropin, chorionic	INJECTABLE;INJECTION	017692-001	Approved Prior to Jan 1, 1982	AP	RX	Yes	Yes		➤ Sign Up				➤ Sign Up
Organon Usa Inc	HUMEGON	menotropins (fsh;lh)	INJECTABLE;INJECTION	020328-002	Sep 1, 1994		DISCN	No	No		➤ Sign Up				➤ Sign Up
Organon Usa Inc	LIQUAEMIN SODIUM	heparin sodium	INJECTABLE;INJECTION	000552-004	Approved Prior to Jan 1, 1982		DISCN	No	No		➤ Sign Up				➤ Sign Up
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211-002	Mar 23, 2004		RX	Yes	Yes	5,929,028	➤ Sign Up	Y			➤ Sign Up
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211-004	Feb 11, 2005		RX	Yes	Yes	7,446,090	➤ Sign Up	Y			➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Organon Usa Inc	REMERON	mirtazapine	TABLET;ORAL	020415-002	Jun 14, 1996	5,977,099	➤ Sign Up
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211-001	Mar 23, 2004	5,767,251	➤ Sign Up
Organon Usa Inc	FOLLISTIM	follitropin alfa/beta	INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS	020582-001	Sep 29, 1997	5,767,251	➤ Sign Up
Organon Usa Inc	REMERON SOLTAB	mirtazapine	TABLET, ORALLY DISINTEGRATING;ORAL	021208-001	Jan 12, 2001	5,977,099	➤ Sign Up
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211-001	Mar 23, 2004	4,589,402	➤ Sign Up
Organon Usa Inc	FOLLISTIM AQ	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021211-001	Mar 23, 2004	5,929,028	➤ Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Injection	250 mcg/0.5 mL, 1 mL PFS	➤ Subscribe	2012-03-30

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2010 00022	Denmark	➤ Sign Up
C0024	France	➤ Sign Up	PRODUCT NAME: CORIFOLLITROPINE ALPHA; REGISTRATION NO/DATE: EU/1/09/609/001 20100125
6/2010	Austria	➤ Sign Up	PRODUCT NAME: CORIFOLLITROPIN ALFA
/1999	Austria	➤ Sign Up	PRODUCT NAME: ETONOGESTREL; NAT. REGISTRATION NO/DATE: 1-22964 19990330; FIRST REGISTRATION: NL 21168 19980825
00C/030	Belgium	➤ Sign Up	PRODUCT NAME: GANIRELIX; REGISTRATION NO/DATE: EU/1/00/130/001 20000518
00016	Netherlands	➤ Sign Up	PRODUCT NAME: GANIRELIX, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT; NATL REGISTRATION NO/DATE: EU/1/00/130/001-002 20000517
Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.